Pharma Partnering Models And Some Uncomfortable Truths?
This article was originally published in Scrip
With multinational pharma groups actively partnering in Asia, a session at the recently concluded BioAsia 2016 in India shed light on the range of collaboration models deployed by Big Pharma across the R&D value chain. It also brought to the fore the tricky terrain that small firms/start-ups must navigate in the world of licensing.
Register for our free email digests: